PTGDS: As a Specific Biomarker for Septic Cardiomyopathy
Our study identifies PTGDS as a novel diagnostic biomarker for sepsis with potential involvement in SCM. These results highlight the potential of PTGDS as a target for future diagnostic development and mechanistic research, paving the way for improved clinical stratification of septic patients at risk of cardiac complications.
Authors
- Yan‐Ming Xu (ORCID: https://orcid.org/0000-0003-1124-0045)
- Chenglin Wang (ORCID: https://orcid.org/0000-0002-6117-6996)
- Yingchun Hu (ORCID: https://orcid.org/0000-0002-5465-4638)
- Linghan Leng
- Yaxing Deng
Institutions
- Affiliated Hospital of Southwest Medical University (CN)
- Chengdu Fifth People's Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/idr.s554915
- Primary Topic
- Medical Imaging and Pathology Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00